Highlights from the August 2021 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic [...]
2021
Introducing the 2021-22 AJKD Editorial Interns
The AJKD editors are excited to continue the Editorial Internship Program for a fourth year, and thank all the fellows who responded to the recent call for [...]
NephMadness 2022: Call for Topic Suggestions
Did we just wrap up NephMadness 2021? Yes. Is it time to plan NephMadness 2022? YES! Which topics would you like to see in next year’s edition of the madness? Now is [...]
Transplant Practices During the COVID-19 Pandemic
In this author interview, AJKD Social Media Editor, Timothy Yau @Maximal_Change, talks to Krista Lentine @KristaLentine, Roslyn Mannon @mannonmom, and Michelle Josephson [...]
HCV D+/R- Kidney Transplantation in the Real-World: Is It Time?
The emergence of direct acting antiviral (DAA) therapy for hepatitis C (HCV) has arguably been one of the most exciting developments in kidney transplantation in the United [...]
Highlights from the July 2021 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic [...]
Will You Take the Blue or Red Pill?
Calcium channel blockers (CCBs) and renin-angiotensin-system inhibitors (RASi) are two classes of antihypertensive medications frequently used as initial therapy for [...]
Could High Be Better Than Low? Targeting Phosphate in Trials
Phosphate is bad, right? As kidney function declines, phosphate excretion goes down. Serum phosphate levels rise, causing parathyroid hormone (PTH) to increase and bring [...]
#PathPointer: Masked Deposits on Kidney Biopsy
PathPointers highlight important everyday teaching points when reviewing kidney histology. These brief and easy-to-read blog posts include real clinical images to demonstrate [...]
A Patient Behavior Modification to Increase Fluid Intake: The PUSH Trial
With the prevalence of urinary stone disease (USD) nearly doubling over the last 15 years, there has been a concomitant rise in the impact it has on our healthcare system. [...]